Company Filing History:
2 out of 13 
2 out of 4 
2 out of 7 
Years Active: 2016-2022
Title: Innovations in Muscle Health: The Contributions of Jean-Denis Durand
Introduction
Jean-Denis Durand is a notable inventor based in Montreuil sous Bois, France. He has made significant contributions to the field of muscle health through his innovative research and patents. With a total of 6 patents, Durand's work focuses on the treatment and prevention of muscle atrophy, a condition that affects many individuals, particularly the elderly and those undergoing rehabilitation.
Latest Patents
Durand's latest patents include groundbreaking inventions that utilize tryptophan metabolites for treating muscle atrophy. One of his notable inventions involves a tryptophan metabolite, specifically chosen from kynurenic acid, anthranilic acid, quinolinic acid, picolinic acid, quinaldic acid, and their mixtures. This invention aims to increase and maintain muscle mass and strength in mammals, particularly for preventing muscle atrophy and promoting muscle growth during exercise. Another significant patent relates to oxime and alkoxy derivatives, which serve as medicaments for treating and preventing muscle atrophy in mammals. These derivatives are designed to limit muscular atrophy and promote muscle growth, especially in exercising mammals.
Career Highlights
Throughout his career, Jean-Denis Durand has worked with prominent companies such as Poxel and Metabrain Research. His work in these organizations has allowed him to further his research and develop innovative solutions for muscle health.
Collaborations
Durand has collaborated with esteemed colleagues, including Franck F Lepifre and Christine G Charon. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Jean-Denis Durand's contributions to the field of muscle health through his innovative patents highlight the importance of research in combating muscle atrophy. His work not only addresses a critical health issue but also paves the way for future advancements in the treatment of muscle-related conditions.